Bandianon, Avelina .

HRN: 27-70-05  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/25/2025
08/31/2025
IV
2.25g
Q8h
Complicated Uti
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines